{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:35:04Z","timestamp":1777347304947,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04765-0","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:44:20Z","timestamp":1773967460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of isolated brainstem bright spotty lesion in a patient with AQP4-positive NMOSD"],"prefix":"10.1186","volume":"26","author":[{"given":"Chlo\u00e9","family":"Froidevaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corentin","family":"Provost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"M\u00e9l\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"2","key":"4765_CR1","first-page":"177","volume":"14","author":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","year":"2015","unstructured":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Wingerchuk al Neurol. 2015;14(2):177\u201389.","journal-title":"Wingerchuk al Neurol"},{"issue":"3","key":"4765_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cei.13630","volume":"206","author":"Clarke","year":"2021","unstructured":"Magnetic resonance imaging in neuromyelitis optica spectrum disorder, Clarke. al Clin Exp Immunol. 2021;206(3):251\u201365.","journal-title":"al Clin Exp Immunol"},{"issue":"11","key":"4765_CR3","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1136\/jnnp-2014-309761","volume":"86","author":"Bright spotty lesions on the spinal cord","year":"2015","unstructured":"Bright spotty lesions on the spinal cord. An additional MRI indicator of neuromyelitis optica spectrum disorder. Hyun & al. J Neurol Neurosurg Psychiatry. 2015;86(11):1280\u20132.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"4765_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/1352458513495581","volume":"20","author":"Bright spotty lesions on","year":"2014","unstructured":"Bright spotty lesions on. spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis. Yonezu al Mult Scler. 2014;20(3):331\u20137.","journal-title":"Yonezu al Mult Scler"},{"issue":"11","key":"4765_CR5","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1177\/1352458521994259","volume":"28","author":"Bright spotty lesions","year":"2022","unstructured":"Bright spotty lesions. as an imaging marker for neuromyelitis optica spectrum disorder. Salama & al. Mult Scler. 2022;28(11):1663\u20136.","journal-title":"Mult Scler"},{"issue":"1","key":"4765_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neurad.2020.04.006","volume":"48","author":"Diagnostic value of bright","year":"2021","unstructured":"Diagnostic value of bright. spotty lesions on MRI after a first episode of acute myelopathy. Rabast\u00e9 & al. J Neuroradiol. 2021;48(1):28\u201336.","journal-title":"J Neuroradiol"},{"issue":"3","key":"4765_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/1352458515591069","volume":"22","author":"Differentiating neuromyelitis optica","year":"2016","unstructured":"Differentiating neuromyelitis optica. from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging. Pekcevik & al. Mult Scler. 2016;22(3):302\u201311.","journal-title":"Mult Scler"},{"key":"4765_CR8","first-page":"396","volume":"15","author":"Spectrum of Auto-antibodies","year":"2024","unstructured":"Spectrum of Auto-antibodies. in NMO and MOG Associated CNS Demyelination- The SANMAD Study. Samim & al. J Neuroimmunol. 2024;15:396.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"4765_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","volume":"271","author":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD)","year":"2024","unstructured":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD). - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management. K\u00fcmpfel & al. J Neurol. 2024;271(1):141\u201376.","journal-title":"J Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04765-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04765-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04765-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:44:55Z","timestamp":1777344295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04765-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4765"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04765-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"284"}}